Eton Pharmaceuticals Inc. (ETON) Misses Q1 EPS by 1c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $8 million versus the consensus estimate of $8.3 million.

As of March 31, 2024, the Company had cash and cash equivalents of $16.7 million and expects continued sales growth to result in positive operating cash flow throughout the remainder of 2024.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Eton Pharmaceuticals (ETON) PT Raised to $65 at H.C. Wainwright
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August